Positron Introduces New Attrius Cardiac PET Scanner

Houston - Positron Corporation introduced their new dedicated Cardiac PET system at the annual meeting of the American Society of Nuclear Cardiology. The meeting attendees consisted of more than 1,500 nuclear cardiologists, practice administrators and technologists with the majority operating myocardial perfusion imaging with private cardiology practices.

Positron's new Attrius molecular imaging system incorporates patented and proprietary software and hardware technology for the diagnosis and treatment of patients with heart disease. Positron Corporation offers a unique combination of low cost technology and disease specific software solutions differentiating themselves from all other medical device manufacturers.

Positron's refocus on cardiology has taken them back to their original core competency which is providing cardiologists with superior imaging tools combined with disease specific software solutions. Market dynamics have changed dramatically since 1983 when the company offered their first cardiac device. The proposed increase in reimbursement in the face of the deficit reduction act, the introduction of new peer reviewed literature suggesting the cost effective benefit of cardiac PET imaging combined with Positron's market entry of a cost effective PET only solution are clear indications of new market development.

Positron Corporation's President, Joseph Oliverio stated, "The Attrius is the only dedicated cardiac PET scanner on the market, which positions the Company in a unique market ascendancy point. Market dynamics combined with our cost effective scanner offering will allow the Company to seize a leading market position as a unique niche player in the nuclear cardiology market segment with virtually no other company offering such a comprehensive solution."

SOURCE: Positron Corporation